Iridium Awarded 5-Year System Infrastructure Transformation and Hybridization Contract Worth Up to $85.8 Million
New Contract Supports Enhancements to the Iridium and U.S. DoD EMSS Service…
InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis
BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE:…
Menarini Group Announces New Data on ELZONRIS (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
Data spans five abstracts including two oral presentations with important findings for…
LEAD INNOVATION CORPORATION and ECLECTIC LIMITED Announce Strategic Collaboration to Explore SPAC Listing and Cross-Border Business Synergies
New York, Nov. 23, 2025 (GLOBE NEWSWIRE) -- LEAD INNOVATION CORPORATION (“LEIC”),…
Algernon Closes First Tranche of its Recently Announced Private Placement Financing
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED…
Breakwater Energy Holdings S. r.l. Announces Pricing of Offering of Senior Secured Notes Due 2030
LUXEMBOURG, Nov. 6, 2025 /PRNewswire/ -- Breakwater Energy Holdings S.à r.l. (the…
Aon Signs Definitive Agreement to Sell Significant Majority of NFP’s Wealth Business to Madison Dearborn Partners
- The agreement includes Wealthspire Advisors, Fiducient Advisors, Newport Private Wealth and…
BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected
Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ…
Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock
September 02, 2025 21:33 ET | Source: Mineralys Therapeutics, Inc. RADNOR, Pa.,…
Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to…